• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • CureVac Appoints Chief Development Officer contractpharma
    June 03, 2021
    ​CureVac N.V., a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), has appointed Klaus Edvardsen, MD, PhD, as chief development officer.
  • Avacta Appoints Chief Development Officer contractpharma
    August 12, 2020
    Neil Bell brings 30 years’ experience in the drug development industry.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service